LEBANON, N.J., June 30, 2020 (Newswire.com) - During this challenging time, MedEvoke is in a unique position to strengthen as an industry leader in global alignment, focusing on developing scientifically compelling narratives and digitally oriented solutions that unify communications and support collaboration to meet the expanding needs of Medical Affairs professionals. Today, MedEvoke announces a key addition to their staff to support their expanding services.
Megan Rachfalski joins MedEvoke as Associate Data Analyst in the Analytics Department. Megan brings experience in data cleaning, modeling, visualization, and machine learning. Applying her informatic skills and focusing her efforts on data mining and client analytics in the digital domain, Megan will draw insights to drive innovative solutions for scientific exchange and clinical trial management initiatives. Megan has a B.S. in Statistics from Virginia Tech.
Marc Sirockman, President of MedEvoke, is on the forefront of understanding how COVID-19 is impacting the biopharmaceutical and device industries, disrupting data generation, data dissemination and stakeholder engagement. Says Sirockman, “Innovative solutions are needed now, more than ever, and on every level to support patient well-being. During this time of change, we strive to find new opportunities and make extraordinary things happen. MedEvoke will be resilient and is prepared to continue to support clients during this time of great uncertainty by adapting and staying calm and focused under pressure to help our clients make difficult choices. Our new hire will contribute to strengthening and expanding our ability to provide innovative insights and solutions to our clients.”
As a premier provider of Medical Affairs solutions for over two decades, MedEvoke specializes in data analysis, cross-functional engagement, and seamless evolution of narrative – and offers its clients a real-time single-source platform that shares “one medical voice” throughout their products’ lifecycles. Expertise ranges from single product launches to life-cycle management to enterprise/portfolio solutions in varied therapeutic categories.
# # #